| AEREA Y POSTAL EX-IAAC | 2024 | 0.001 | KG | ETORICOXIB, LGC, S/M ETORICOXIB ESTANDARES PARA ANALISIS EN LABORATORIO PRESENTACION: 250 MG, CODIGO: MM0965.00, LOTE: G1080090 | GERMANY | SPAIN | 1565 |
| AEREA Y POSTAL EX-IAAC | 2024 | 100 | KG | 2H-1,2,4-Benzithiadiazine-7-sulfonamide, 6 -chloro-3,4-dihydro-,1,1-dioxide, S/M, S/M 2H-1,2,4-Benzithiadiazine-7-sulfonamide, 6 -chloro-3,4-dihydro-,1,1-dioxide MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | INDIA | SPAIN | 3250.32 |
| AEREA Y POSTAL EX-IAAC | 2024 | 2.5 | KG | (4S,6S)-4-(ETHYL AMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO [2,3-B] THIOPYRAN-2-SULFONAMIDE 7,7 (4S,6S)-4-(ETHYL AMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO [2,3-B] THIOPYRAN-2-SULFONAMIDE 7,7 MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 5021.64 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.01 | KG | 5-[(2R)-2-[[2-(2-ETHOXY-PHENOXY)ETHYL LAMINOLPROPYL] BENZENE SULFONAMIDE, S/M, S/M 5-[(2R)-2-[[2-(2-ETHOXY-PHENOXY)ETHYL LAMINOLPROPYL] BENZENE SULFONAMIDE COMERCIALIZADO EN KG//1 = 1 MG Working estándarpara analisis en laboratorio | INDIA | SPAIN | 0.33 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.1 | KG | 5-[(2R)-2-[[2-(2-ETHOXY-PHENOXY)ETHYL LAMINOLPROPYL] BENZENE SULFONAMIDE, S/M, S/M 5-[(2R)-2-[[2-(2-ETHOXY-PHENOXY)ETHYL LAMINOLPROPYL] BENZENE SULFONAMIDE COMERCIALIZADO EN KG//MUESTRA//1 =10 GR Muestra para analisis en laboratorio | INDIA | SPAIN | 0.33 |
| MARITIMA DEL CALLAO | 2024 | 100 | KG | 5-acetamido 1,3,4-thiadiazole-2-sulfonamide, S/M, S/M 5-acetamido 1,3,4-thiadiazole-2-sulfonamide MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | INDIA | HONG KONG | 11686 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.059 | KG | HIDROCLOROTIAZIDA, UPS, S/M Hydrochlorothiazide (200 mg) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION: 1U = 200 MG, CODIGO: 1314009, LOTE: R15770 | ITALY | UNITED STATES | 267.4 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.2 | KG | all trans-retinoic acid --- (302-79-4), S/M, S/M all trans-retinoic acid --- (302-79-4) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | CHINA | CHINA | 1035 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.25 | KG | all trans-retinoic acid ---(302-79-4), S/M, S/M all trans-retinoic acid ---(302-79-4) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | CHINA | CHINA | 1370 |
| AEREA Y POSTAL EX-IAAC | 2024 | 1.3 | KG | Coá-[á-(5,6-dimethylbenzimidazol-yl)]-Coá- hydroxocobamide acetate, S/M, S/M Coá-[á-(5,6-dimethylbenzimidazol-yl)]-Coá- hydroxocobamide acetate Materia Prima para fabricación de medicamentos. COMERCIALIZADO EN KILOGRAMOS | MEXICO | MEXICO | 10752.5 |
| AEREA Y POSTAL EX-IAAC | 2024 | 3 | KG | CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]MET CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]MET MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 8454 |
| AEREA Y POSTAL EX-IAAC | 2024 | 3 | KG | CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL], S CALCIUM ( 2S)-2-[[4-[[[(6RS)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]MET MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | HONG KONG | 7542 |